Gradient Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-113
| Closed | -$27.5K | – | 331 |
|
|
2024
Q2 | $27.5K | Buy |
113
+1
| +0.9% | +$243 | ﹤0.01% | 587 |
|
|
2024
Q1 | $16.7K | Sell |
112
-2
| -2% | -$299 | ﹤0.01% | 577 |
|
|
2023
Q4 | $21.8K | Hold |
114
| – | – | ﹤0.01% | 691 |
|
|
2023
Q3 | $20.2K | Sell |
114
-2
| -2% | -$354 | ﹤0.01% | 679 |
|
|
2023
Q2 | $22K | Buy |
116
+6
| +5% | +$1.14K | ﹤0.01% | 670 |
|
|
2023
Q1 | $22K | Sell |
110
-1
| -0.9% | -$200 | ﹤0.01% | 663 |
|
|
2022
Q4 | $26.4K | Buy |
111
+1
| +0.9% | +$238 | ﹤0.01% | 634 |
|
|
2022
Q3 | $22K | Hold |
110
| – | – | ﹤0.01% | 646 |
|
|
2022
Q2 | $16K | Hold |
110
| – | – | ﹤0.01% | 680 |
|
|
2022
Q1 | $18K | Hold |
110
| – | – | ﹤0.01% | 663 |
|
|
2021
Q4 | $19K | Hold |
110
| – | – | ﹤0.01% | 669 |
|
|
2021
Q3 | $21K | Hold |
110
| – | – | ﹤0.01% | 629 |
|
|
2021
Q2 | $19K | Hold |
110
| – | – | ﹤0.01% | 644 |
|
|
2021
Q1 | $16K | Hold |
110
| – | – | ﹤0.01% | 657 |
|
|
2020
Q4 | $16K | Hold |
110
| – | – | ﹤0.01% | 607 |
|
|
2020
Q3 | $16K | Hold |
110
| – | – | ﹤0.01% | 611 |
|
|
2020
Q2 | $16K | Hold |
110
| – | – | ﹤0.01% | 562 |
|
|
2020
Q1 | $12K | Hold |
110
| – | – | ﹤0.01% | 606 |
|
|
2019
Q4 | $13K | Hold |
110
| – | – | ﹤0.01% | 634 |
|
|
2019
Q3 | $9K | Hold |
110
| – | – | ﹤0.01% | 678 |
|
|
2019
Q2 | $8K | Buy |
+110
| New | +$8K | ﹤0.01% | 695 |
|